Table 1.
Demographic Characteristics of HSCT Recipients with Moderate Risk TA-TMA (N = 48)
Variable | Value |
---|---|
Male sex, n (%) | 23 (47.9) |
Age at transplantation, yr, median (IQR) | 7.3 (3.4–13) |
Race, n (%) | |
Caucasian | 40 (85.1) |
African American | 6 (12.8) |
Asian | 0 (0) |
Mixed | 1 (2.1) |
Diagnostic group, n (%) | |
Malignancy | 16 (33.3) |
Immune deficiency | 10 (20.8) |
Marrow failure | 13 (27.1) |
Benign hematology | 6 (12.5) |
Genetic/metabolic | 3 (6.2) |
Stem cell donor type, n (%) | |
Related (MRD, MMRD) | 13 (27.1) |
Unrelated (MUD, MMUD) | 30 (62.5) |
Autologous | 5 (10.4) |
Stem cell source, n (%) | |
Bone marrow | 31 (64.6) |
Peripheral blood | 15 (31.2) |
Cord blood | 2 (4.2) |
HLA match (allogeneic-HSCT only), n (%) | |
Fully matched (MRD, MUD) | 28 (65.1) |
Mismatched (MMR, MMUD, haploidentical) | 15 (34.9) |
Conditioning regimen type, n (%) | |
Myeloablative | 30 (62.5) |
Reduced intensity | 18 (37.5) |
GVHD prophylaxis (allogeneic HSCT only), n (%) | |
CNIs | 34 (81) |
T cell depletion | 6 (10.7) |
MRD indicates matched related donor; MMRD, mismatched related donor; MUD, matched unrelated donor; MMUD, mismatched unrelated donor.